Core Laboratories (CLB) Change in Receivables (2022 - 2026)

Core Laboratories' Change in Receivables history runs 5 years deep, the most recent figure standing at -$5.0 million for Q1 2026.

• On a quarterly basis, Change in Receivables fell 175.84% year-over-year to -$5.0 million in Q1 2026; TTM through Mar 2026 was -$6.7 million, a 269.63% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, up 37.13% from the prior year.
• Change in Receivables eased to -$5.0 million in Q1 2026 per CLB's latest filing, from $4.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $6.7 million in Q4 2022 and bottomed at -$5.8 million in Q4 2024.
• The 5-year median for Change in Receivables is $1.2 million (2022), against an average of $936600.0.
• Across the five-year window, Change in Receivables jumped 182.08% in 2024 and tumbled 496.3% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $6.7 million in 2022, then declined by 17.91% to $5.5 million in 2023, then plunged by 206.54% to -$5.8 million in 2024, then soared by 174.17% to $4.3 million in 2025, then sank by 215.49% to -$5.0 million in 2026.
• Per Business Quant, the three latest CLB Change in Receivables figures stand at -$5.0 million (Q1 2026), $4.3 million (Q4 2025), and -$3.1 million (Q3 2025).